10, CD, I
AP_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N10, CD, I
GLM_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N16, CD, I
AP_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N16, CD, I
GRM_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N17, CD, I
AP_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N17, CD, I
GLM_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N22, CD, I
AP_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N22, CD, I
GLL_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N23, CD, I
AP_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N23, CD, I
GLL_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N26, CD, I
AP_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N26, CD, I
GLM_genomic, NNP, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, NBisulphite, NNP, I
converted, VBD, I
DNA, NNP, I
from, IN, I
24, CD, I
visceral, JJ, I
adipose, JJ, N
tissue, NN, N
(VAT), NN, I
samples, NNS, I
were, VBD, I
hybridised, VBN, I
to, TO, I
the, DT, I
Illumina, NNP, I
Infinium, NNP, I
HumanMethylation450, NNP, I
Beadchip., NNP, IBisulphite, NNP, I
converted, VBD, I
DNA, NNP, I
from, IN, I
the, DT, I
71, CD, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N
samples, NNS, I
were, VBD, I
hybridised, VBN, I
to, TO, I
the, DT, I
Illumina, NNP, I
Infinium, NNP, I
450k, CD, I
Human, NNP, I
Methylation, NNP, I
Beadchip., NNP, IBisulphite, NNP, I
converted, VBD, I
DNA, NNP, I
from, IN, I
the, DT, I
71, CD, I
visceral, JJ, I
adipose, JJ, N
tissue, NN, N
samples, NNS, I
were, VBD, I
hybridised, VBN, I
to, TO, I
the, DT, I
Illumina, NNP, I
Infinium, NNP, I
450k, CD, I
Human, NNP, I
Methylation, NNP, I
Beadchip., NNP, IBy, IN, I
combining, VBG, I
both, DT, I
data, NNS, I
sets, NNS, I
we, PRP, I
identified, VBD, I
a, DT, I
highly, RB, I
significant, JJ, I
set, NN, I
of, IN, I
depot-specifically, RB, I
expressed, VBN, I
genes, NNS, I
that, WDT, I
appear, VBP, I
to, TO, I
be, VB, I
epigenetically, RB, I
regulated., JJ, ICells, NNP, I
able, JJ, I
to, TO, I
form, VB, I
bone, NN, I
through, IN, I
endochondral, JJ, I
ossification, NN, I
and, CC, I
attract, VB, I
bone, NN, I
marrow, NN, I
in, IN, I
an, DT, I
innovative, JJ, I
in, IN, I
vivo, JJ, I
model, NN, I
were, VBD, I
compared, VBN, I
to, TO, I
cells, NNS, I
lacking, VBG, I
these, DT, I
capacities., NNS, IComparing, VBG, I
four, CD, I
commonly, RB, I
use, VBP, I
MSC, NNP, I
sources, NNS, I
(bone, VBP, I
marrow, JJ, I
(BM), NNP, I
white, JJ, I
adipose, JJ, N
tissue, NN, N
(WAT), NNP, I
umbilical, JJ, I
cord, NN, I
(UC), NN, I
and, CC, I
skin), NN, I
we, PRP, I
found, VBD, I
only, RB, I
bone, JJ, I
marrow, JJ, I
(BM)-derived, JJ, I
MSCs, NNP, I
capable, NN, I
of, IN, I
endochondral, JJ, I
ossification, NN, I
and, CC, I
marrow, NN, I
attraction., NN, IContributor:, NNP, I
the, DT, I
Multiple, NNP, I
Tissue, NNP, I
Human, NNP, I
Expression, NNP, I
Resource, NNP, I
Consortium, NNP, IControls, NNS, I
for, IN, I
unmethylated, JJ, I
and, CC, I
methylated, JJ, I
DNA, NNP, I
were, VBD, I
represented, VBN, I
respectively, RB, I
by, IN, I
whole-genome, JJ, I
amplified, JJ, I
DNA, NN, I
from, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N
(using, VBG, I
the, DT, I
GenomiPhi, NNP, I
DNA, NNP, I
amplification, NN, I
kit;, NN, I
GE, NNP, I
Healthcare, NNP, I
Piscataway, NNP, I
NJ, NNP, I
USA), NNP, I
and, CC, I
the, DT, I
universal, NN, I
methylated, VBD, I
human, JJ, I
DNA, NNP, I
standard, NN, I
(Zymo, NNP, I
Research)., NNP, IDataset, NNP, I
includes, VBZ, I
32, CD, I
samples, NNS, I
from, IN, I
Germany., NNP, IDespite, IN, I
similarities, NNS, I
in, IN, I
morphology, NN, I
phenotype, NN, I
and, CC, I
in, IN, I
vitro, JJ, I
behavior, NN, I
Mesenchymal, NNP, I
Stromal, NNP, I
Cells, NNP, I
(MSC), NNP, I
form, VBP, I
various, JJ, I
tissue, NN, I
sources, NNS, I
show, VBP, I
striking, JJ, I
differences, NNS, I
in, IN, I
their, PRP$, I
in, IN, I
vivo, NN, I
potential, NN, I
to, TO, I
form, VB, I
bone, NN, I
cartilage, NN, I
and, CC, I
hematopoietic, JJ, I
support, NN, I
tissue., NN, IDNA, NN, I
methylation, NN, I
analysis, NN, I
of, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N
abdominal, JJ, I
versus, NN, I
subcutenaous, JJ, I
adipose, JJ, N
tissue, NN, N
gluteal, NN, IDNA, NN, I
methylation, NN, I
analysis, NN, I
of, IN, I
the, DT, I
total, JJ, I
72, CD, I
tissue, NN, I
samples, NNS, I
and, CC, I
controls, NNS, I
was, VBD, I
performed, VBN, I
with, IN, I
the, DT, I
Illumina, NNP, I
Infinium, NNP, I
HumanMethylation450, NNP, I
BeadChip., NNP, IDNA, NN, I
methylation, NN, I
profiles, NNS, I
of, IN, I
abdominal, JJ, I
adipose, JJ, N
tissue, NN, N
(6, NNP, I
samples), NN, I
and, CC, I
gluteal, NN, I
adipose, JJ, N
tissue, NN, N
(6, NNP, I
samples), NN, I
were, VBD, I
generated, VBN, I
using, VBG, I
Infinium, NNP, I
methylation, NN, I
450K, CD, I
BeadChips, NNP, I
from, IN, I
Illumina, NNP, I
(Illumina, NNP, I
San, NNP, I
Diego, NNP, I
USA)., NNP, IEpigenome, JJ, I
analysis, NN, I
of, IN, I
the, DT, I
human, JJ, I
subqutaneous, JJ, I
adipose, NN, N
tissue, NN, NEpigenome, JJ, I
analysis, NN, I
of, IN, I
the, DT, I
human, JJ, I
visceral, JJ, I
adipose, NN, N
tissue, NN, NGene, NNP, I
expression, NN, I
was, VBD, I
analyzed, VBN, I
in, IN, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N
from, IN, I
9, CD, I
women, NNS, I
in, IN, I
each, DT, I
group., NN, IGene, NNP, I
methylation, NN, I
profiles, NNS, I
in, IN, I
visceral, JJ, I
adipose, JJ, N
tissue, NN, N
of, IN, I
obese, JJ, I
men, NNS, I
with, IN, I
and, CC, I
without, IN, I
the, DT, I
metabolic, JJ, I
syndrome, NN, Igenomic, JJ, I
DNA, NN, I
from, IN, I
human, JJ, I
adipose, JJ, N
tissue, NN, NHowever, RB, I
the, DT, I
molecular, JJ, I
basis, NN, I
of, IN, I
depot-specific, JJ, I
characteristics, NNS, I
is, VBZ, I
not, RB, I
completely, RB, I
understood, JJ, I
yet., NN, IIn, IN, I
a, DT, I
secondary, JJ, I
analysis, NN, I
we, PRP, I
examined, VBD, I
DNA, NNP, I
methylation, NN, I
and, CC, I
expression, NN, I
of, IN, I
adipogenesis, NN, I
genes, NNS, I
in, IN, I
15, CD, I
and, CC, I
11, CD, I
obese, JJ, I
women, NNS, I
respectively., VBP, IIndeed, RB, I
triglycerides, NNS, I
and, CC, I
fatty, JJ, I
acids, NNS, I
of, IN, I
abdominal, JJ, I
adipose, JJ, N
tissue, NN, N
were, VBD, I
more, RBR, I
saturated, JJ, I
compared, VBN, I
to, TO, I
triglycerides, NNS, I
and, CC, I
fatty, JJ, I
acids, NNS, I
in, IN, I
gluteal, NN, I
adipose, JJ, N
tissue, NN, N
., ., IIn, IN, I
humans, NNS, I
adipose, JJ, N
tissue, NN, N
is, VBZ, I
distributed, VBN, I
in, IN, I
subcutaneous, JJ, I
abdominal, JJ, I
and, CC, I
subcutaneous, JJ, I
gluteal, NN, I
depots, NNS, I
that, WDT, I
comprise, VBP, I
a, DT, I
variety, NN, I
of, IN, I
functional, JJ, I
differences., NN, IInterestingly, RB, I
only, RB, I
BM-derived, JJ, I
MSPCs, NNS, I
were, VBD, I
capable, JJ, I
of, IN, I
bone, NN, I
formation, NN, I
and, CC, I
marrow, NN, I
attraction., NN, IInterestingly, RB, I
the, DT, I
majority, NN, I
of, IN, I
these, DT, I
genes, NNS, I
form, VBP, I
part, NN, I
of, IN, I
the, DT, I
homeobox, NN, I
gene, NN, I
family., NN, IIn, IN, I
this, DT, I
study, NN, I
we, PRP, I
have, VBP, I
analyzed, VBN, I
DNA, NNP, I
methylation, NN, I
characteristics, NNS, I
of, IN, I
human, JJ, I
mesenchymal, JJ, I
stem, NN, I
and, CC, I
progenitor, NN, I
cells, NNS, I
(MSPCs), JJ, I
form, JJ, I
different, JJ, I
tissue, NN, I
sources, NNS, I
including, VBG, I
bone, NN, I
marrow, NN, I
(BM), NNP, I
white, JJ, I
adipose, JJ, N
tissue, NN, N
(WAT, NN, I
), ), I
umbilical, JJ, I
cord, NN, I
(UC), NN, I
as, RB, I
well, RB, I
as, IN, I
dermal, JJ, I
fibroblasts, NNS, I
by, IN, I
using, VBG, I
the, DT, I
HumanMethylation450K, NNP, I
array., NN, ILiver, NNP, I
tissue, NN, I
samples, NNS, I
were, VBD, I
obtained, VBN, I
from, IN, I
severely, RB, I
obese, JJ, I
individuals, NNS, I
that, WDT, I
underwent, VBP, I
bariatric, JJ, I
surgery., NN, IMesenchymal, JJ, I
stem, NN, I
and, CC, I
progenitor, NN, I
cells, NNS, I
(MSPCs), VBP, I
from, IN, I
human, JJ, I
white, JJ, I
adipose, JJ, N
tissue, NN, N
(WAT), NN, IMoreover, RB, I
genes, NNS, I
involved, VBN, I
in, IN, I
fatty, JJ, I
acid, JJ, I
metabolism, NN, I
were, VBD, I
also, RB, I
differentially, RB, I
expressed., VB, IMuscle, NNP, I
tissue, NN, I
samples, NNS, I
were, VBD, I
obtained, VBN, I
from, IN, I
severely, RB, I
obese, JJ, I
individuals, NNS, I
that, WDT, I
underwent, VBP, I
bariatric, JJ, I
surgery., NN, Inormal, JJ, I
adipose, JJ, N
tissue, NN, N
sample, NN, Iseverely, RB, I
obese, JJ, I
patient_Subqutaneous, JJ, I
adipose, JJ, N
tissue, NN, Nseverely, RB, I
obese, JJ, I
patient_visceral, JJ, I
adipose, JJ, N
tissue, NN, Nsubcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N
abdominal, NN, Isubcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N
gluteal, NN, ISubcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N
samples, NNS, I
were, VBD, I
obtained, VBN, I
from, IN, I
severely, RB, I
obese, JJ, I
individuals, NNS, I
that, WDT, I
underwent, VBP, I
bariatric, JJ, I
surgery., NN, ISubjects/Methods:, NNP, I
Genome-wide, NNP, I
DNA, NNP, I
methylation, NN, I
was, VBD, I
analyzed, VBN, I
in, IN, I
abdominal, JJ, I
subcutaneous, JJ, I
fat, NN, I
cells, NNS, I
from, IN, I
16, CD, I
women, NNS, I
examined, VBD, I
two, CD, I
years, NNS, I
after, IN, I
gastric, JJ, I
bypass, NN, I
surgery, NN, I
at, IN, I
a, DT, I
post-obese, JJ, I
state, NN, I
(BMI, VBD, I
26±2 kg/m2, CD, I
mean±s.d.), NN, ITaken, VBN, I
together, RB, I
our, PRP$, I
results, NNS, I
uncover, RB, I
clear, JJ, I
differences, NNS, I
between, IN, I
abdominal, JJ, I
and, CC, I
gluteal, JJ, I
adipose, JJ, N
tissue, NN, N
on, IN, I
the, DT, I
gene, NN, I
expression, NN, I
and, CC, I
DNA, NNP, I
methylation, NN, I
level, NN, I
as, RB, I
well, RB, I
as, IN, I
in, IN, I
fatty, JJ, I
acid, NN, I
composition., NN, IThe, DT, I
17, CD, I
post-mortem, JJ, I
human, JJ, I
somatic, JJ, I
tissues, NNS, I
used, VBN, I
in, IN, I
this, DT, I
study, NN, I
were, VBD, I
collected, VBN, I
at, IN, I
the, DT, I
time, NN, I
of, IN, I
autopsy., NN, IThe, DT, I
goal, NN, I
of, IN, I
the, DT, I
study, NN, I
was, VBD, I
to, TO, I
evalute, VB, I
the, DT, I
relationship, NN, I
between, IN, I
body, NN, I
mass, NN, I
index, NN, I
and, CC, I
DNA, NNP, I
methylation, NN, I
levels., NN, IThe, DT, I
goal, NN, I
of, IN, I
this, DT, I
study, NN, I
was, VBD, I
to, TO, I
identify, VB, I
tissue, NN, I
specific, JJ, I
methylation, NN, I
QTLs., NNP, IThe, DT, I
Illumina, NNP, I
Infinium, NNP, I
450k, CD, I
Human, NNP, I
DNA, NNP, I
methylation, NN, I
Beadchip, NNP, I
v1.2, NN, I
was, VBD, I
used, VBN, I
to, TO, I
obtain, VB, I
DNA, NNP, I
methylation, NN, I
profiles, NNS, I
across, IN, I
approximately, RB, I
485000, CD, I
CpGs., NNP, ITherefore, RB, I
a, DT, I
detailed, JJ, I
molecular, JJ, I
characterization, NN, I
of, IN, I
adipose, JJ, N
tissue, NN, N
depots, NNS, I
will, MD, I
be, VB, I
essential, JJ, I
to, TO, I
develop, VB, I
new, JJ, I
treatment, NN, I
strategies, NNS, I
for, IN, I
metabolic, JJ, I
syndrome, NN, I
associated, VBN, I
complications., NN, ITherefore, IN, I
we, PRP, I
suppose, VBP, I
that, IN, I
changes, NNS, I
in, IN, I
gene, NN, I
expression, NN, I
profiles, NNS, I
might, MD, I
account, VB, I
for, IN, I
depot-specific, JJ, I
differences, NNS, I
in, IN, I
lipid, JJ, I
composition., NN, IThese, DT, I
features, NNS, I
correlated, VBD, I
with, IN, I
unique, JJ, I
epigenetic, JJ, I
characteristics, NNS, I
potentially, RB, I
enabling, VBG, I
BM-derived, NNP, I
cells, NNS, I
to, TO, I
undergo, VB, I
endochondral, JJ, I
ossification., NN, Itisse, NN, I
source, NN, I
for, IN, I
mscs:, JJ, I
white, JJ, I
adipose, JJ, N
tissue, NN, N
(WAT), NN, Itissue:, RB, I
Subqutaneous, NNP, I
adipose, JJ, N
tissue, NN, Ntissue:, JJ, I
visceral, JJ, I
adipose, JJ, N
tissue, NN, Ntissue:, JJ, I
Visceral, NNP, I
adipose, NN, N
tissue, NN, NTo, TO, I
gain, VB, I
mechanistic, JJ, I
insights, NNS, I
explaining, VBG, I
this, DT, I
differences, VBZ, I
we, PRP, I
analyzed, VBD, I
gene, NN, I
expression, NN, I
characteristics, NNS, I
of, IN, I
MSC, NNP, I
from, IN, I
all, DT, I
four, CD, I
tissue, NN, I
sources, NNS, I
using, VBG, I
Affymetrix, NNP, I
Genechip, NNP, I
Human, NNP, I
Gene, NNP, I
2.0, CD, I
ST, NNP, I
Array., NNP, ITo, TO, I
investigate, VB, I
the, DT, I
role, NN, I
of, IN, I
epigenetic, JJ, I
regulation, NN, I
in, IN, I
depot-specific, JJ, I
gene, NN, I
expression, NN, I
we, PRP, I
additionally, RB, I
analyzed, VBD, I
genome-wide, JJ, I
DNA, NNP, I
methylation, NN, I
patterns, NNS, I
in, IN, I
abdominal, JJ, I
and, CC, I
gluteal, JJ, I
depots., NN, IUsing, VBG, I
array-based, JJ, I
analyses, NNS, I
of, IN, I
transcription, NN, I
profiles, NNS, I
we, PRP, I
identified, VBD, I
a, DT, I
specific, JJ, I
set, NN, I
of, IN, I
genes, NNS, I
that, WDT, I
was, VBD, I
differentially, RB, I
expressed, VBN, I
between, IN, I
subcutaneous, JJ, I
abdominal, JJ, I
and, CC, I
gluteal, JJ, I
adipose, JJ, N
tissue, NN, N
., ., IVisceral, NNP, I
adipose, JJ, N
tissue, NN, N
from, IN, I
obese, JJ, I
men, NNS, I
with, IN, I
the, DT, I
metabolic, JJ, I
syndrome, NN, I
(MetS+, NNP, I
N=7), NNP, I
vs., IN, I
obese, JJ, I
men, NNS, I
without, IN, I
the, DT, I
metabolic, JJ, I
syndrome, JJ, I
(MetS-, JJ, I
N=7), NN, IVisceral, NNP, I
adipose, JJ, N
tissue, NN, N
samples, NNS, I
were, VBD, I
obtained, VBN, I
from, IN, I
severely, RB, I
obese, JJ, I
individuals, NNS, I
that, WDT, I
underwent, VBP, I
bariatric, JJ, I
surgery., NN, IVisceral, NNP, I
adipose, JJ, N
tissue, NN, N
was, VBD, I
obtained, VBN, I
during, IN, I
biliopancreatic, JJ, I
diversion, NN, I
surgery, NN, IVisceral, NNP, I
adipose, JJ, N
tissue, NN, N
was, VBD, I
obtained, VBN, I
during, IN, I
biliopancreatic, JJ, I
diversion, NN, I
surgery, NN, I
rapidly, RB, I
frozen, VBD, I
in, IN, I
liquid, NN, I
N2, NNP, I
and, CC, I
stored, VBN, I
at, IN, I
-80, NNP, I
oC., NN, IWe, PRP, I
had, VBD, I
two, CD, I
technical, JJ, I
and, CC, I
two, CD, I
biological, JJ, I
replicates, NNS, I
processed, VBN, I
by, IN, I
chip, NN, I
technique., NN, IWhereas, NNP, I
energy, NN, I
storage, NN, I
in, IN, I
gluteal, NN, I
adipose, JJ, N
tissue, NN, N
has, VBZ, I
been, VBN, I
shown, VBN, I
to, TO, I
mediate, VB, I
a, DT, I
protective, JJ, I
effect, NN, I
an, DT, I
increase, NN, I
of, IN, I
abdominal, JJ, I
adipose, JJ, N
tissue, NN, N
is, VBZ, I
associated, VBN, I
with, IN, I
metabolic, JJ, I
disorders., NN, IWhole-transcriptome, JJ, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N
methylation, NN, I
levels, NNS, I
were, VBD, I
determined, VBN, I
in, IN, I
60, CD, I
individuals, NNS, I
with, IN, I
a, DT, I
BMI, NNP, I
>35, NNP, I
kg/m2., NN, IWhole-transcriptome, JJ, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N
methylation, NN, I
levels, NNS, I
were, VBD, I
determined, VBN, I
in, IN, I
67, CD, I
individuals, NNS, I
with, IN, I
a, DT, I
BMI, NNP, I
>35, NNP, I
kg/m2., NN, IWhole-transcriptome, JJ, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N
methylation, NN, I
levels, NNS, I
were, VBD, I
determined, VBN, I
in, IN, I
71, CD, I
individuals, NNS, I
with, IN, I
a, DT, I
BMI, NNP, I
>35, NNP, I
kg/m2., NN, IWhole-transcriptome, JJ, I
subcutaneous, JJ, I
adipose, JJ, N
tissue, NN, N
methylation, NN, I
levels, NNS, I
were, VBD, I
determined, VBN, I
in, IN, I
71, CD, I
individuals, NNS, I
with, IN, I
a, DT, I
BMI, NNP, I
>35, NNP, I
kg/m2., NN, I